Company Filing History:
Years Active: 2011
Title: Achim Freisleben: Innovator in Pharmaceutical Chemistry
Introduction
Achim Freisleben is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on creating effective treatments for various diseases, showcasing his dedication to improving healthcare.
Latest Patents
Achim Freisleben holds a patent for "Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases." This invention relates to 4,6-disubstituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof. The patent outlines their use as pharmaceutically active agents for the prophylaxis and treatment of infectious diseases, including opportunistic diseases, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases, and stroke. Additionally, the invention discusses the use of these derivatives as inhibitors for a protein kinase and their application in enriching, purifying, and depleting nucleotide binding proteins.
Career Highlights
Throughout his career, Achim Freisleben has worked with prominent companies in the pharmaceutical industry. He has been associated with Lead Discovery Center GmbH and Bayer Pharma Aktiengesellschaft, where he has contributed to various research and development projects. His expertise in pharmaceutical chemistry has allowed him to make impactful advancements in drug discovery and development.
Collaborations
Achim has collaborated with notable professionals in his field, including Axel Choidas and Alexander Backes. These collaborations have further enhanced his research and development efforts, leading to innovative solutions in pharmaceutical applications.
Conclusion
Achim Freisleben's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work continues to influence the development of effective treatments for a range of diseases, highlighting the importance of innovation in healthcare.